This is a preview of subscription content, log in via an institution to check access.
Literature Cited
V. A. Vinogradov, S. E. Spevak, K. N. Yarygin, et al., Byull. Éksp. Biol. Med.,, No. 7, 89 (1987).
V. P. Grigorevskii, R. N. Korotkina, and A. A. Karelin, Byull. Éksp. Biol. Med., No. 10, 428 (1989).
M. I. Kuzin, A. A. Karelin, R. N. Korotkina, et al., Byull. Éksp. Biol. Med., No. 9, 266 (1988).
Yu. B. Lishmanov, Byull. Éksp. Biol. Med., No. 9, 271 (1986).
Yu. B. Lishmanov, N. F. Brattsev, and S. A. Lambina, Abstracts of Proceedings of the First All-Union, Conference on Neuropeptides, their Role in Physiology and Pathology [in Russian], Tomsk (1985), pp. 92–93.
S. R. Mardashev and V. A. Burobin, Vopr. Med. Khim., No. 3, 320 (1962).
V. S. Pavlenko, “Participation of opioid peptides in the pathogenesis of experimental acute myocardial infarction,” Dissertation for the Degree of Candidate of Medical Sciences, Tomsk (1986).
V. D. Slepushkin, V. S. Pavlenko, V. V. Khlystov, et al., Byull. Vses. Kardiol. Nauch. Tsent. SSSR, No. 2, 54 (1986).
V. V. Khlystov and V. S. Pavlenko, Arkh. Patol., No. 3, 72 (1988).
B. L. Horecker and L. A. Heppel, Methods in Enzymology, ed. by S.P. Colowick and N.O. Kaplan, Vol. 2, New York (1955), pp. 482–485.
O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, J. Biol. Chem.,193, No. 1, 265 (1951).
H. Ohkawa, N. Ohishi, and Y. Kunio, Analyt. Biochem.,95, No. 2, 351 (1979).
M. Warholm, C. Gutenberg, C. von Bahr, and B. Mannervik, Methods in Enzymology, ed. by A. Meister, Vol. 113, New York (1985), pp. 499–501.
Rights and permissions
About this article
Cite this article
Korotkina, R.N., Fomchenkov, E.P., Andreev, V.I. et al. Some molecular mechanisms of the antioxidative action of dalargin on the liver in experimental cholestasis. Bull Exp Biol Med 113, 52–55 (1992). https://doi.org/10.1007/BF00787744
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00787744